[Federal Register Volume 64, Number 144 (Wednesday, July 28, 1999)]
[Notices]
[Page 40874]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-19235]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability and Injury Prevention and Control Special 
Emphasis Panel: Nutritional Biochemistry Cooperative Agreements for 
Innovative Technology Development Grant for Detection and Monitoring of 
Diabetic Hypoglycemia by Non- or Minimally-Invasive Techniques

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following meeting.

    Name: Disease, Disability and Injury Prevention and Control 
Special Emphasis Panel: Nutritional Biochemistry Cooperative 
Agreements for Innovative Technology Development Grant for Detection 
and Monitoring of Diabetic Hypoglycemia by Non-or Minimally-Invasive 
Techniques, Program Announcement #99151.
    Times and Dates: 8:30 a.m.-9 a.m., August 12, 1999 (Open); 9 
a.m.-5 p.m., August 12, 1999 (Closed); 9 a.m.-4 p.m., August 13, 
1999 (Closed).
    Place: Atlanta Marriott North Central, 2000 Century Boulevard 
NE, Atlanta, Ga. 30345-3377. Telephone 404/325-0000.
    Status: Portions of the meeting will be closed to the public in 
accordance with provisions set forth in section 552b(c)(4) and (6), 
Title 5 U.S.C., and the Determination of the Associate Director for 
Management and Operations, CDC, pursuant to Public Law 92-463.
    Matters to be Discussed: The meeting will include the review, 
discussion, and evaluation of applications received in response to 
Program Announcement #99151.
    Contact Person for More Information: Dayton T. Miller, Ph.D., 
Chief, Nutritional Biochemistry Branch, NCEH, CDC, 4770 Buford Hwy., 
m/s F18, Atlanta, Ga. 30341-3724. Telephone 770/488-4579, e-mail 
[email protected].
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register Notices pertaining 
to announcements of meetings and other committee management 
activities, for the both the Centers for Disease Control and 
Prevention and the Agency for Toxic Substances and Disease Registry.

    Dated: July 22, 1999.
Carolyn J. Russell,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention (CDC).
[FR Doc. 99-19235 Filed 7-27-99; 8:45 am]
BILLING CODE 4163-18-P